Chronic hepatitis C

Effect of Treatment with Direct Acting Antiviral on Glycemic Control in Patients with Diabetes Mellitus and Chronic Hepatitis C
6

Insulin resistance and steatosis in chronic hepatitis C
9

Vitamin D deficiency and vitamin D therapy in chronic hepatitis C
6

Module VPredictive factors for response to treatment of chronic hepatitis C
5

Serum lipids and chronic hepatitis C genotype 4: interaction and significance
10

Interferon based therapy delays but metabolic comorbidity accelerates progression of chronic hepatitis C
10

Prevalence of insulin resistance in chronic hepatitis C genotype 1 and 3 patients
5

Effects of Age on Treatment of Chronic Hepatitis C with Direct Acting Antivirals
10

Treatment of chronic hepatitis C virus infection in the near future
6

Side effects of medical therapy for chronic hepatitis C
7

Risk factors for liver fibrosis progression in patients with chronic hepatitis C
8

Chronic Hepatitis C Treatment with Direct Acting Antiviral Agents in a Real Life Setting
9

Clinical and epidemiological features of 147 Chilean patients with chronic hepatitis C
7

Direct Acting Antiviral Therapy Outcomes in Canadian Chronic Hepatitis C Telemedicine Patients
7

Long term changes in liver histology following treatment of chronic hepatitis C virus
10

Recreational Drug and Psychosocial Profile in Chronic Hepatitis C Patients Seeking Antiviral Therapy
9

Alcoholic intake predisposes to more interface hepatitis in chronic hepatitis C
9

Liver specific case fatality due to chronic hepatitis C virus infection: a systematic review
13

Frequency and Characteristics of Occult Hepatitis B Infection Among Hepatocellular Carcinoma Patients in Japan
8

Burden of Chronic Viral Hepatitis and Liver Cirrhosis in Brazil the Brazilian Global Burden of Disease Study
8